Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,481 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Docetaxel plus epirubicin as first-line chemotherapy in MBC (KCSG 01-10-05): phase II trial and the predictive values of circulating HER2 extracellular domain and vascular endothelial growth factor.
Im SA, Kim SB, Lee MH, Im YH, Lee KH, Song HS, Lee MA, Lee J, Lee NS, Ham HS, Kim TY, Park YH, Lee KE, Kim KW, Seo JH, Lee SN, Hong YS, Bang YJ, Kim WK, Park HS. Im SA, et al. Among authors: park yh, park hs. Oncol Rep. 2005 Aug;14(2):481-7. Oncol Rep. 2005. PMID: 16012734 Clinical Trial.
A phase II study of gemcitabine in combination with oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancer.
Kim HJ, Lee NS, Lee SC, Bae SB, Kim CK, Cheon YG, Kim YS, Moon JH, Cho YD, Park SH, Lee KT, Park SK, Won JH, Park HS, Hong DS. Kim HJ, et al. Among authors: park hs, park sk, park sh. Cancer Chemother Pharmacol. 2009 Jul;64(2):371-7. doi: 10.1007/s00280-008-0883-7. Epub 2009 Jan 14. Cancer Chemother Pharmacol. 2009. PMID: 19142638 Clinical Trial.
Randomized, multi-center phase II trial of docetaxel plus cisplatin versus etoposide plus cisplatin as the first-line therapy for patients with advanced non-small cell lung cancer.
Lee NS, Park HS, Won JH, Hong DS, Uh ST, Lee SJ, Kim JH, Kim SK, Ahn MJ, Choi JH, Yang SC, Lee JA, Lee KS, Yim CY, Lee YC, Kim CS, Lee MH, Jung KD, Moon H, Lee YS. Lee NS, et al. Among authors: park hs. Cancer Res Treat. 2005 Dec;37(6):332-8. doi: 10.4143/crt.2005.37.6.332. Epub 2005 Dec 31. Cancer Res Treat. 2005. PMID: 19956368 Free PMC article.
5,481 results